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European intervention trials, European nutrient databases and European nutrigenomics 
networks – such are the biomedical infrastructures that convey a sense of a European sci-
ence of nutrition and health. Beyond the EUropeanness of its organizational networks, 
these biomedical projects also produce segmentations of European populations in terms 
of biological difference, e.g. in statements such as, “half of the Europeans express no 
GSTM1 enzyme” or “nearly half of the Europeans are slow acetylators.”1 These com-
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munications perform the “European” as at least one among many reference categories 
in biomedical research. However, late 20th century biomedical research does not envi-
sion this “European” as made up by typological characteristics, but rather along sets 
and segments of statistical frequencies. Often, a host of differences within, rather than 
any unifying characteristics, are exposed. Beyond addressing the “European” explicitly, 
much of the actual production of the “European” is rather implicit. Key mechanisms 
here include the effects of EU-wide standardizations of knowledge production, and the 
stabilization of a universalized rationality as well as a certain habitus of the European 
citizen and consumer.
This article examines the production, imagination and reification of a contemporary 
Homo Europaeus at several levels: While there is a somehow presupposed and at times 
bio-statistically described “European” on the one hand, there is a continued re-emergence 
of the “European” produced at a bureaucratic level of the European Union harmoniza-
tion processes on the other hand. We will describe some features of how this “European” 
is configured as risk manager and bio-participant in the field of nutrition and health, in 
particular, in a research setting of nutritional epidemiology. 
Much of biomedical research has been driven by “applied” research fields, such as “nu-
trition and health”. Technologies of sequencing and bio-banking have prompted a host 
of sub-disciplines and approaches. These emerging research fields frame nutrition and 
health in terms of risk factors and markers that have emerged from genomic technolo-
gies, such as nutritional genomics, transcriptomics, proteomics, metabolomics, and bio-
informatics,2 to name a few of these highly specialized, technology-bound research areas. 
Beyond the techniques of molecular biology, formalizations of nutrition studies take 
place in population studies of “modern epidemiology“3. We refer to the approach of 
risk factor epidemiology as extended laboratory of epidemiological studies that include 
surveys, observational studies and prevention trials conducted in defined samples of the 
population. 
Today, millions of people in Europe participate in epidemiological studies. Epidemio-
logical studies often include large samples of the population in defined geographic areas 
and collect individual data on lifestyle and dietary habits. Moreover, they ask participants 
to undergo basic physical examinations and consent to make their medical records ac-
cessible to the study. While at the collective level, epidemiological reasoning is part of 
a culture of statistical risk assessment, these practices do not go without reconfiguring 
the ways in which the body, health and disease are understood and concepts of being a 
citizen-participant and a (potential) patient conceptualized and lived. In order to under-
stand these regimes of knowledge generation, we examine the emergent Homo Europaeus 
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This article broadens the perspective to include the more implicit processes of how the 
contemporary Homo Europaeus is constituted, as individuals and groups become subject 
to and engage with practices and processes labeled “EUropean.” We explore how research 
into nutrition and health produces the “European” both in generating scientific knowl-
edge about a European population and in developing and performing a “European ap-
proach” within “global” biomedicine. Recent research into the history of ‘the European’ 
has mostly focused on social constructions of the Homo Europaeus in institutions and 
specific policy settings.4 Social scientists and anthropologists have examined how “eating 
and drinking are acts of identification, differentiation and integration, particularly in the 
social areas of ethnicity and national identity.”5 These studies describe eating and drink-
ing cultures as key to the negotiation of belonging to a certain group or imagined com-
munity. In our case, we ask how eating and drinking of the “European” is transformed 
into an object of quantitative knowledge production. In other words, we explore how 
contemporary biomedical sciences make sense of nutrition and health and how, in this 
process, they reconfigure and perform the “European.” By looking closely at the methods 
of recruitment, data collecting and risk assessments, this approach can highlight not only 
the reconfiguration of notions of food and health, but also focus the re-territorializations 
that take place in relation to the contemporary Homo Europaeus. The modes of knowl-
edge production and consumption discussed in this article are by no means only Euro-
pean, but they are made European in the ways they are performed and enacted within a 
European infrastructure. 
This article is divided into four sections: we will first look into the making of data infra-
structures by researchers and participants of a multicentre European study; second, we 
follow the research practices from recruitment to statistical modeling. We then discuss 
how, in global research consortia of contemporary nutritional epidemiology, Europeans 
are construed in opposition to non-Europeans; we trace the categories of interests to 
epidemiology, along which subpopulations are constructed. Finally, we look into health 
policy contexts for the ways in which the study results circulate back to “European” 
societies, e.g., in nutrition and health monitoring and in “targeted” public health inter-
ventions. 
1. Doing the epidemiological assemblage: researchers and participants 
For the exploration of epidemiological studies, we found inspiration in the concept of 
“assemblage”6 to think about the heterogeneity of epidemiological practices. In the heter-
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ables meet, when exposure data on nutrition, genetics, and lifestyle are examined for sta-
tistical associations with disease frequencies. While data variables from different contexts 
can become statistical “risk factors”, the conceptual matrix of disease causation is under 
incessant negotiation. In their inherent knowledge economy, successful epidemiological 
studies need to be open enough to integrate new variables and generate novel etiological 
hypotheses. In that sense, they function as productive research systems,7 as constellations 
within which new research questions can emerge. Epidemiological research systems in-
clude the study designs, questionnaires, protocols, collaborators, institutions, repositor-
ies of data and samples, offices, hardware and software. Our case – the EPIC study, a 
European multicenter study in nutritional epidemiology – was implemented in the early 
1990s with combined funding that included a major contribution from the European 
Union’s, then new, public health research agenda of 1992, as part of the program “Eu-
rope Against Cancer.” The overall number of participants from 12 European countries 
amounts to more than half a million. In what follows, we refer mostly to two centers in 
Germany and in Denmark, where our empirical research took place. In this first section, 
we approach the epidemiological assemblage through its human actors – researchers and 
participants.
A principle investigator describes the European dimension of the study first and foremost 
as a “fantastic long-term collaboration of very different people, opinions and perspectives 
over 20 years,” and as a highly productive project in terms of publications, produced by 
many working groups using the data resources for their specific topics. Thus it is the 
research infrastructure on the one hand that is European, due to its financial support for 
infrastructure building, which provided research groups in Europe with the means to 
set up and implement a population study using standardized techniques. On the other 
hand, in the very process of this research, “Europeans” become a specific population tar-
geted by biomedical research. Hence, “EUrope” is more than a funding institution, the 
European population is both the “object” of research, as well as the “funder” and, later, 
the targeted “consumer” of results. Professional practitioners of risk assessment represent 
one contemporary version of the Homo Europaeus as risk assessors aiming at optimizing 
European population health. 
Managed encounters: recruitment and participation
The first contact between researchers and participants takes place during recruitment:8 
Participants are contacted with a letter of invitation that introduces the aims of the study 
and proposes an appointment. In both the former East German study center and in 
Denmark, the study was presented in public as mainly a local project. In the German 
case, this was a deliberate consideration in the early 1990s, addressing the recent change 
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ponders, confronting participants with the idea that “now it is about Europe” just four 
years after the reunification would hardly have worked. In the Danish case, this was dif-
ferent and the emphasis was on the local level9 and the study was given the Danish title 
“Kost, kræft og helbred (Diet, Cancer and Health)”. Like the other Scandinavian EPIC 
projects, it was first and foremost conducted as a local study, but also embedded in the 
European network from the beginning. The fact that this was a multicenter study at the 
European level did not play a major role in communications for recruitment, but was 
an important feature for the researchers from the beginning. To epidemiologists, it was 
clear that only very large numbers would allow investigations into small differences in 
dietary habits and their role in disease causation, particularly in rare cancers and the then 
emergent field of gene-lifestyle interactions. Framing this process in the terms of actor-
network-theory, the interessement10 that draws researchers to the study is in the database 
as empirical resource for biomedical research. The negotiations of interessement for par-
ticipants are less straightforward and those agreeing to participate often expect benefits 
and, even though at no point promised by the study, some diagnostic results that would 
be relevant to their own health.  
Within Europe, the working infrastructures in which the epidemiological studies are 
embedded differ depending on context and on country and region – this was also the 
case for the EPIC study. As to the situation in Germany, recruitment for epidemiological 
studies is generally viewed as difficult and epidemiologists are often struggling with low 
response rates.11 The implications of low and differential response are a major concern 
as to the validity of any epidemiological study, leading to different strategies of framing 
the study in public communications. In both cases, the fact that the study was part of a 
European multicenter study was not emphasized. In the East German case, the Institute 
for Nutrition Research that conducted the study had already been renowned in East 
Germany before 1989. Officially recognized in the “Blue List” of those research institutes 
selected to obtain continued state funding while much of the East German research 
infrastructure was closed down, the institute stood to some extent for continuity, which 
was valued by residents in the region and local nutrition scientists. Thus for participants 
from the region, the research institute, with the inception of a new study in 1993, gave 
a sense of stability beyond the radical political and economic restructuring that led to 
disappearance of nearly the entire former societal institutions of the GDR. 
In Denmark the inception of the study started as an entirely local project under the title 
“Kost, Kræft og Helbred” (Diet, Cancer, and Health) with Danish funding. That there 
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was an add-on through the European study only played a minor role in the implementa-
tion of the study. Studies on research participation in Denmark also showed that most 
citizens view their participation in medical research as “giving something back” to the 
state health care system from which they benefit.12 There is also a major difference in 
conditions for epidemiological projects between Germany and Denmark: Whereas in 
many countries data on diagnoses need to be collected and obtained via questionnaires 
and individual consent needs to be obtained, epidemiologists in the Nordic countries 
can draw on central registries via record linkage, for instance to obtain information on 
cancer diagnoses. This feature of a central registry infrastructure made the conditions for 
the Scandinavian EPIC studies particularly favourable.13 
Together the different local recruitment efforts conducted for the multicenter study have 
resulted in a European population study on nutrition and health. Once all variables 
were quantified and transformed into databases, an epidemiological research platform14 
became available for statistical scrutiny and modeling of population health. 
Transforming eating and drinking into numerical datasets 
In order to create an empirical knowledge base, nutrition scientists need to establish and 
maintain logistics to enroll thousands of participants in examinations and in question-
naire surveys. Nutrition questionnaires play a key role as an instrument to transform the 
everyday eating habits of individual participants into quantitative variables. By means of 
this transformation, nutrition data is integrated into the framework of risk factor epide-
miology.15 Filling in these questionnaires can take several hours and requires an active 
translation of one’s eating and drinking practices into the categories on the questionnaire. 
The study design also comprised standardized medical and anthropometric examinations 
and detailed questionnaires on nutrition, lifestyle and health. Several interviewed par-
ticipants stated that they enjoy completing the questionnaires and that the latter do not 
pose particular problems. Others found that the questions relating to frequency of eat-
ing particular food items or consumption of beverages were not that straightforward, as 
they required a particular mode of knowledge production and transfer. For instance, the 
questionnaires demand average consumptions and gave little space for the irregularities 
of everyday life that make up the social realities of eating and drinking habits. One of the 
informants pointed out that she can eat a whole bar of chocolate during one evening, but 
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to estimate averages over longer periods of time and doing abstractions from the irregular 
realities of everyday life in which many different social circumstances and constellations 
of work and leisure activities can be spontaneous rather than habitual. Much of nutrition 
seems to resist quantification and notions of regularity. Participants sometimes felt that 
they had to adapt their accounts to the items on the questionnaires “in order to bring 
their practices of everyday life into the format of a statistical average.” The participants 
we interviewed were well aware of this “translation” of much more complex realities of 
their everyday lives while striving to deliver the required data on average intakes. A par-
ticipant in the Danish pilot study pointed out that she and her husband enthusiastically 
complete every questionnaire from health authorities as well as from marketing surveys 
and that it was interesting to see how many details of everyday life are of relevance to 
these scientific studies. Together with the desire to do something useful for science, there 
were also moments of exploration of these categories as to one’s everyday life, which was 
about playing with and probing the categories of the questionnaire. Knowledge exchange 
was conceived of as giving something back to medical science, but also to tentatively 
adopt an outside, “scientific” perspective on one’s own life. 
Filling in a standardized questionnaire required participants to engage with the catego-
ries and standards of the study. Participants who repeatedly were asked to complete 
follow-up questionnaires experienced this, once enrolled in the study, as an obligation. 
There is both reassurance and a sense of imposed duty that was reported with having 
made the “choice” of participation. When they were late filling in the questionnaires they 
had obtained via mail participants described having “a bad conscience”; they felt obliged 
to comply with the study protocol as participant. The multiple written reminders and 
subsequently phone calls they obtain from the institute also reinforce these obligations. 
These can function in the mode of interpellation, described by Althusser to enroll sub-
jects into the authority exercised by an apparatus that calls them to act in particular 
ways.16 
Bioparticipation: Samples for future research
Like many epidemiological studies in the age of genomics, the EPIC study also included 
storage of DNA in a biobank. Most of the centers collected and stored blood samples, 
while some centers, among them the Danish study, additionally collected more biologi-
cal materials, including urine, adipose tissue and toenail clippings from each participant. 
While, like in genomics, there is much hype in the emerging field of “molecular epide-
miology”, biobanking practices have raised controversy, in particular as to the informed 
consent process with regard to the future, largely yet unknown usages of these repositor-
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ies.17 Interestingly, research with blood samples is not considered to require informed 
consent in the US, while the European bioethics position foresees an explicit informed 
consent procedure or, at least opt-out possibilities, for secondary studies that reuse ma-
terials. Thus, human biological samples do not have the same status – what they are and 
how they are to be dealt with may differ, not only between scientists and the public, but 
also between European and North American regulatory frameworks.18
When samples are stored as material resources even beyond the lives of individual par-
ticipants, there is a specific configuration of temporal regimes – there seems to be a sus-
pension of time with the freezing of samples. Participants’ samples are stored to remain 
there for the future – in that sense, relations of participants with the study are preserved 
via frozen samples. There is a continued “frozen participation” – with this – a term with 
which we also allude to the highly regulated ways epidemiological research takes place 
and in which participants as research subjects have but little agency. The samples of a 
biobank are linked to the epidemiological database, which contains data on dietary hab-
its and health of the people who donated the samples to research. With as of yet unclear 
future usage of these samples, new biomarkers are expected to become relevant; here, this 
inherent notion of scientific progress creates the infrastructures, co-shaping what will be 
possible in future research. 
The remaking of citizens with biotechnologies in the age of biomedicine has been ad-
dressed with the concepts of biosociality19 and in particular bio-citizenship.20 Some stud-
ies have conceptualized biocitizenship as a mode of enacting citizenship by participating 
in a study or survey; others criticize the concept for reducing more important debates 
on citizenship into notions of choice or duty and argue for a closer look at the complex 
social relations in which these are entrenched.21 We propose the term “bio-participation” 
to account for the ambivalence of becoming a research subject. With the notion of bio-
participation, we are not arguing for improved regimes of accountability to participants; 
we propose to use the term as an analytical device to explore and understand how “par-
ticipation” in epidemiological studies is enacted. Significantly, in the categorization as 
“active participants” in the follow-up routines of epidemiological studies, being “active” 
seems to go together with being passive in terms of subjecting oneself to the highly regu-
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participation are heterogeneous and there are multiple ways of dealing with, handling, or 
resisting the “choices” or “duties” to serve biomedical research.22 The visits and interac-
tion with staff of the institute as well as their letters and reminders enact a duty to par-
ticipate. This duty blends into understandings of modes of citizenship, co-construed by 
participation as representation in surveys. In the mode of bio-participation, participants 
are, rather than acting as citizen-participants, subjected to a regime of biocitizenship. In 
that context, filling in a questionnaire, donating a blood sample for research, receiving 
recommendations and adopting an attitude of prevention are part of a regime of tech-
nologies of the self and a mode of contemporary citizenship co-shaped by European 
bureaucratic processes.23
2. Data work: calibrating, follow-up, modeling 
Drawing attention to the mundane techniques that play a key role in what biotechnolo-
gies do, Hannah Landecker has proposed to take as point of departure the technological 
practices which are routinely described in the “materials and methods” sections of re-
search publications.24 We adopt the approach for the cultural study of biosciences by ex-
amining the materials and methods of data work in epidemiology. Here, the knowledge 
production setting entails a sequence of steps, comprised of study design, recruitment, 
data gathering, validation and risk modeling. In what follows, we discuss those for the 
calibrations, follow-up of participants for data and the development of data platforms for 
hypotheses testing. Infrastructure building and the recombination of data are prerequi-
sites of epidemiological studies. The routine infrastructures of data storing and classify-
ing play a key role in health research and clinical practice.25 
European calibrations: the quantification of nutrition 
The scientific approach to nutrition comprises the quantification of food intake as a first 
and crucial step; once quantified, they can serve as a cumulative exposure estimate for 
epidemiological studies. Epidemiologists operationalize nutrition in various formats, for 
instance as consumed nutrients or energy intake calculated for each food item and fre-
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become a set of quantitative exposure variables. These can be calculated and rendered 
comparable in standardized modes based on the data obtained by participants’ responses 
in the questionnaires. Thus, as a first step, nutritional epidemiology generates quantita-
tive data on consumed food products for each individual, using standardized measures. 
Epidemiologists calculate nutrients and energy intake based on questionnaire data on 
the various food groups – from meat to salad dressings, and from bread to fruits, with 
detailed amounts of single items such as apples or citrus fruits. 
The challenges of such a study are mostly in the harmonization of data and methods to 
“measure” nutrition, in particular for the pooled European dataset. In the EPIC study, 
the questionnaires contain standardized core modules, but also allow for local variation 
between countries in order to cover regionally specific diets. Ensuring compatibility be-
tween different questionnaires required much standardization. This includes conducting 
so-called calibration studies for a subsample of participants from all centers. In calibration 
studies two methods of measurement are compared, by introducing a third questionnaire 
for comparison as a reference. For a calibration study within the EPIC network, 40,000 
participants of the study were randomly selected from all local cohorts.26 They were then 
asked to fill in an additional questionnaire, now exactly the same one for all different 
centers. The purpose of this additional exercise was to calibrate the instruments with 
which data have been recorded. For example, the questionnaires on fruit and vegetable 
consumption in countries such as Norway and Greece are not directly compatible, since 
questionnaires are developed locally and take into account the specificities of local eating 
cultures. In this situation, calibration via the standard made compatible different instru-
ments without introducing systematic errors.
Following participants for data: follow-up and record linkage
The respective conditions for epidemiological research differ between participating Euro-
pean centers, e.g., between Scandinavian countries with central population registries and 
countries without cancer registries. For instance in Germany, there is no central cancer 
registry and therefore direct record linkage to obtain information on cancer diagnoses 
among participants is not possible. To obtain health-related data, a complex data collec-
tion protocol needs to be developed that is based on self-reported data from question-
naires and informed consent for contacting GPs and hospitals in order for confirmation. 
In our interviews with epidemiologists in Denmark, researchers stressed the fact that 
they do not need to do follow-up studies, for there are central population registries they 
can link up with (via unique person-numbers). Registries include the “cancer registry, the 
hospital discharge registry, the cause of death registry, CPR for addresses and relocations, 
Statistics Denmark for socio-economic data a database for school health records through 
the Institute for Preventive Medicine, from which we get birth weight and weight during 
2	 The	recruited	sample	was	weighted	by	expected	cancer	rates,	which	was	estimated	based	on	total	rates	by	age	
and	gender.
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years at school, … and the prescriptions registry.”27 Registry research has a long tradi-
tion in Denmark and represents a major part of epidemiological activities.28 Similar to 
other Nordic countries, the use of this health care system data for public health research 
is largely unquestioned. These “ideal conditions for research in which the whole country 
can be conceived as a cohort”29 for epidemiological research are often considered a com-
petitive resource in international comparison.
From descriptive analyses to platforms for hypotheses testing 
In comparison to other factors, the overall influence of nutrition on chronic disease is 
considered to be weak. Therefore a certain variation in nutrition, as it is the case within 
a multicenter European study are considered advantageous and, for instance, there is 
considerable variation as to fruit and vegetable consumption between Northern Europe 
and Greece. Descriptive data on these differences, e.g., the range of vegetable consump-
tion, was published as reference material for the study. In these descriptive presentations, 
columns of numerical data on average intakes of food groups such as fruits, vegetables 
or meat products in grams per day, adjusted by age, season and day of the week are pre-
sented. Displayed in a standardized way, the intake of certain foods becomes comparable 
between countries and study regions.30 A quantitative inventory of nutrition is produced 
for the population under study, which generates composite measures that can be com-
pared across the different study centers in Europe. The choice of regions listed in the 
table is that of the participating study centers and their recruitment strategies. The study 
populations were mostly from regions adjacent to the involved research centers; this also 
reflects institutional and personal networks between scientists. 
While such descriptive analyses are often presented as part of the materials and meth-
ods sections, the actual aim of cohort studies, however, is to investigate the associations 
between exposures/risk factors and disease. In order to test etiological hypotheses, the 
influences of dietary habits, markers of genetic variation such as polymorphisms, and 
haplotypes in relation to disease outcomes are modeled, thereby calculating e.g., the risk 
of disease, based on the data collected during follow-ups. The modeling is statistically 
complex. The final configuration of model parameters is based on careful assessment of 
correlations between variables and statistical significance tests. Technically, risk estimates 
can be derived from these models in terms of subgroup-specific risk or overall risk esti-
mates for the entire study population (then usually under adjustment for age, gender, 
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study center are listed in tables, the variables “region / center” or “country” are invisible 
in the actual reporting of results.31 The hypotheses are about nutrition, lifestyle, genetics 
and health outcomes, while center or region is only a technical or instrumental variable 
in the logistics of the study in order to secure “sufficient difference in exposure.” 
Agudo et al. (2006) have then stratified for genetic polymorphism and smoking in order 
to investigate possible interactions; this is one of the gene-lifestyle interactions studies 
in further analyses. The empirical database of the study population is the resource to 
scrutinize novel hypotheses; in that way, the central database of a multicenter study 
functions as a testing platform for parameters that influence population health. Large 
multicenter studies are – despite the complex standardization processes such as calibra-
tion of instruments – of importance to epidemiologists in order to study the influence of 
‘weak’ risk factors such as particular food groups or to study rare cancers. In this context, 
the European network provides research opportunities in terms of jointly observing and 
comparing a large overall study population with different dietary habits.
3. “European diversity” as a resource for knowledge production
The Endeavours to study complex associations between genetics, lifestyle and nutrition 
and disease aim for even larger data structures. Only very large studies can achieve the 
sample sizes required to perform statistically meaningful hypotheses testing to address 
the challenge of multifactorial models with a host of weak but interacting factors. This is 
due to new variables emerging from genomics, the plethora of biomarkers in the field of 
molecular epidemiology and renewed attention to complex interactions. So far, this arti-
cle has followed the local epidemiological studies up towards the European level. In this 
part, we explore how this European database, as constituted in the study, is then inte-
grated into more global, universalizing knowledge production about disease causation.
As in genomics and biobanking, epidemiologists have established international data in-
frastructures in the quest for ever-larger samples that pool data from millions of par-
ticipants to study complex “gene-environment interactions” in genomic epidemiology.32 
The pooling of datasets in so-called “global consortia” is a rather novel phenomenon, 
which became possible with data sharing technologies. Information technologies have 
been instrumental in making epidemiology – previously, from rather local research at the 
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The reification of the “European” as a biomedical category 
With genomic epidemiology developing into “big science,” researchers increasingly need 
to attach their study to larger consortia in order to keep up with methodological require-
ments. The hypotheses formalized in these global consortia range from the influence of 
genetic polymorphisms or haplotypes, combined with lifestyle variables on cancer,34 to 
consortia that examine BMI (body mass index) and mortality in population samples large 
enough to study, like in toxicology, dose-response relationships, for instance between a 
lifestyle variable and cancer incidence.35 These projects pool dozens of very large cohorts, 
mostly from North American, European and Asian studies. In these pooled datasets the 
notion of the “European” re-emerges, persists and circulates. In some pooling projects 
the “Europeans” are referred to, jointly with “white Americans”, as “Caucasians”.36 The 
latter categories are used until the present in censuses and much of the biomedical re-
search conducted in North America since the mid-1990s. They became routine with the 
implementation of guidelines at the level of the US National Institutes of Health, which 
demand specification and inclusion of “minority” populations in biomedical research.37 
Since European researchers produce publications and data for an international knowl-
edge economy, they frame their own data in the terms and formats that are compatible 
with international standards and categories. For studies conducted in Europe, authors 
add to their methods descriptions attributes such as “among mostly Caucasian Germans” 
or “in more than 95% of Caucasians.” This is to facilitate inclusion in global meta-
analyses38 and in order to make the studies compatible with the predominant biomedical 
categories of globalized biomedicine, which often use the US census classification as a 
standard. How these categories of “European, White, and Caucasian” are operational-
ized, however, can remain rather open: While in biomedicine these population categories 
sometimes run synonymously with ethnicity, in epidemiology they are often used as a 
flexible surrogate variable,39 which stand for something else: for further differentiation 
that can be conceptualized as biological or social. Often, the self-identified US-census 
category “race” is routinely included40 and then, sometimes tacitly, interpreted in terms 
of difference either in exposure, social status or genetics. 
34	 See	studies	by	 the	Breast	and	Prostate	Cancer	Cohort	Consortium	 (BPC3):	www.epi.grants.cancer.gov/BPC3/	
(accessed	30	June	2009)
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Hence, the European as a population category, only emerges in the comparison to a 
non-European “other”: Asian, African populations, or Caucasian North Americans. The 
construction of the category of European as different from a non-European “other,” be it 
the oriental, the Asian, the African, has a colonial history in which western biomedicine 
is deeply entrenched.41 Europe is constructed as homogeneous in certain ways, at least 
when viewed from outside or in comparison with the non-European “other.” While 
region and regional diversity are of significance within Europe, the “European” remains 
heterogeneous unless the data is pooled with American cohorts: Then, the European 
becomes homogeneous, sometimes reifying categories of Euro-American „race science“, 
such as racialized labels “Caucasian”. 
Difference as a resource: creating a European research platform
While epidemiology has increasingly developed into big science, with large-scale multi-
center studies prioritized for reasons of statistical power, some researchers have expressed 
concerns about limitations of these very large studies. Their concerns include monopoli-
zation effects if all studies are pooled into a global mega-study. One of the concerns here 
is that once all data are synthesized, the findings cannot be challenged by competing 
studies and, given just one global pool, there would be no independent database left to 
test these results. While mainstream science aims to establish ever larger data structures 
that allow multiple statistical tests, others question the sole aim of increasing the sample 
size and argue for several consortia. Referring to the principle of falsification, it is argued 
that there should be opportunities to “compare these findings in a second study and 
could … benefit from a test-retest situation”.42 
Quantitative comparison and the estimation of difference are the principle tools in epi-
demiological research. This requires differentials that can be used for calibration and 
that ensure that variation becomes measurable. Nutritional epidemiologists stress that 
“Europeans”, as a study population, exhibit regionally specific, quite different dietary 
habits, which they see as advantage of their study population. Differences in dietary 
patterns that result from the regional diversity of food products are operationalized for 
epidemiological association studies to link exposure variables such as nutrition to health 
and disease at the population level. Research questions posed to the data include whether 
there are regional influences, for example if being overweight is a regional phenomenon, 
i.e., whether there is a higher risk in Italy, Greece and Spain or in Northern Europe – and 
whether there are differences in latency periods. Epidemiologists require some degree of 
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conceived as a quasi-experimental opportunity to study the influence of nutrition on hu-
man health in a much more general sense. These opportunities are used to estimate dif-
ferences in disease risks between flexible subgroups with different dietary habits. In the 
context of epidemiological studies, regional characteristics – different from the emphasis 
on place and the local in notions of terroir43 – function rather instrumentally: difference 
is “taken advantage” of for study purposes – in the textbook tradition of “natural experi-
ments.”44 Regional difference in eating cultures is transformed into a “quasi-experiment,” 
which then can be used as a matrix to generate and test novel hypotheses. The geographic 
differentiation of the initial stage is transformed into another flexible segmentation of 
the population according to epidemiological variables. 
4. The re-circulation of European nutrition and health estimates into society 
In addition to the investigation of the role of nutrition in disease causation, the Euro-
pean Commission has funded applied projects aimed at developing nutrition recom-
mendations. A large-scale project titled EuroDiet (1998–2000)45 was set up with the 
goal of “translating” scientific knowledge, e.g., from studies in nutritional epidemiology, 
into public health policy. For these translations into policies, risk estimates are used to 
estimate the reduction of risk by a particular change or intervention. This implies that 
epidemiological findings are considered robust enough to be transferred to another set-
ting, e.g., made relevant to population health in general. If this is the case, risk estimates 
– e.g., of a reduction in relative risk of developing a disease when eating a certain amount 
of fruits and vegetables by some precise factor – leave the epidemiological research and 
begin circulating as “immutable mobiles”.46 In this way, they enter health policies but 
also clinical medicine. 
EuroDiet: from research to policy 
The field of public health has played an important role in the European funding frame-
works since 1992, when the Maastricht Public Health Framework, including five spe-
cific action programs – cancer, Aids, drug dependency, health promotion and health 
monitoring – was adopted. A good example of the research strategies of the European 
framework provides the project “EuroDiet” and its aim to develop tools in order to en-
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to inform health policy.”47 The goal of “EuroDiet” was the “development of European 
dietary guidelines, which will provide a framework for the development by member 
states of national food-based dietary targets”, 48 and it included leading scientists, policy 
advisors, national and European agencies, NGOs, food industry, educational, social, 
cultural consumer organisations.
To achieve the translation from research to policy, four groups to work on “health & nu-
trients,” “nutrients & food,” “foods & people,” and “people & policies” were set up. The 
design of these successive work packages moves “from nutrients to people,” thus taking 
the opposite approach of epidemiological studies: The epidemiologic research process, 
translates everyday life habits into data on eating and drinking, obtained via question-
naire. These undergo transformation through multivariate modeling, resulting in aggre-
gate risk estimates. In the opposite way, the step-wise translation agenda of “EuroDiet” 
takes the risk estimates and translates them back to modify and optimize the eating and 
drinking practices in order to improve population health. The division of the project into 
work packages is organized along stages of these translations: its point of departure are 
the risk estimates for nutrients in relation to health; from there the project recontextual-
ized that format of knowledge in terms of actual food and food groups; subsequently, 
“foods and people” and “people and policies” take these results to policies and to the in-
dividual citizen. This conceptualization renders risk estimates as a European knowledge 
base for successive translation into dietary policy. That this scientific “Europeanness” 
is performed across administrative and policy levels evokes a homogeneous scientific 
dietary principle. Based on the health patterns in Europe and associations with dietary 
patterns measured in nutrients, scientists formulate nutrient targets for “effective food-
based dietary recommendations,” which in turn are consulted for “health promoting 
changes in eating and physical activity patterns”.49 The latter then enter a re-design of the 
broader policy framework. As those are based on evidence from risk factor epidemiology, 
this successive translation pushes frameworks of prevention from socio-economic factors 
toward individualized notions of “lifestyle choices”. 
Evidence-based medicine and evidence-based policy as European  
governance model?
“Practical European guidelines for diet-related disease prevention and health promo-
tion”50 were developed to translate the scientific evidence into European policy frame-
works. Analyzing the tactics to make such translations happen can shed some light on 
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multiple uncertainties, these are managed in order to successfully establish a theory or 
a connection by simultaneously employing several methods that provide a cumulative 
or “global certainty,” even though knowledge of local fields might be uncertain. A fur-
ther tactic identified by Leigh Star and described for epidemiology by Janet Shim is the 
“displacement of epistemological questions with lower-level technical debates.”52 With 
this “scientification” of health policy and economic accountability, much decision-mak-
ing is based or justified by drawing on epidemiologic findings. This, however, is not a 
specifically EU-European path, but a general trend of Western governance models. These 
modes of governance increasingly draw on “scientific evidence” and adopt a model simi-
lar to evidence-based medicine,53 but now in the context of policy-making.
Other domains in which epidemiological studies circulate back to society include risk 
assessments in clinical and preventive medicine. A number of scores for clinical risk as-
sessments are in use, but only a few of them take nutrition into account. Rather, most of 
them address nutrition-related factors in terms of biomarkers measured in blood, such as 
cholesterol levels.54 The European cardiovascular risk score, “Systematic Coronary Risk 
Evaluation” (SCORE), recommended by the European Society of Cardiology, is one such 
tool. Displayed on color, paper charts or in electronic format, the tool provides a system 
of classification stratified by gender, age, smoker/non-smoker and gives risk figures55 for 
the 10 year risk of fatal CVD in populations at high or low risk. The score is based on 
cohort and mortality data in Europe and calculates risk estimates for high and low risk 
countries – it performs a division of Europe into high risk (Northern Europe) and low 
risk (Mediterranean) countries. This can be viewed as a “biomedicalized reterritorializa-
tion” of Europe into high and low-risk countries with respect to cardiovascular risk. This 
difference in risk is then enacted in clinical practice, which may lead to different clinical 
decisions for patients with otherwise the same profile, depending on whether he/she lives 
in high or low risk countries, i.e., Germany or Switzerland, Belgium or France. Physi-
cians working with evidence-based medicine and drawing on these studies actively use 
these categories when talking to the public and to patients. In these re-individualizations, 
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In the field of nutrition and health, public health recommendations are part of primary 
prevention policies. However, only a few nutrition-related factors are considered as hav-
ing enough support by scientific evidence. While, for instance, salt intake, folic acid, 
and iodine supplementation are included in EU policies and recommendations, only 
the increase of breastfeeding, fruit & vegetable consumption and physical activity are 
considered robust enough in terms of the available evidence. Already in the EuroDiet 
report, it is these three factors that remain in terms of specific goals after the “translation 
process” and consideration of the “evidence base.” Given the high profile of biomedical 
nutrition research, these key areas of policy action seem rather modest. Increasing fruit 
consumption is one such recommendation – at an international level a campaign to in-
crease fruit and vegetable consumption has been conducted – the “5 Per Day” campaign. 
The German Nutrition Society follows that global recommendation after a WHO study 
on prevention of chronic disease recommended to eat 400 grams fruits / vegetables a day 
or more. In Denmark, a similar campaign called “6 Per Day” was started by the Danish 
Cancer Society and the Danish Ministry of Food, Agriculture and Fisheries. The Dan-
ish “6 Per Day” website explains core strategies of the Danish campaign: From “maybe 
600 grams or more” to “6 Per Day,”56 they see as necessary a science of behavior change, 
intervention research, communication science, but also lobbying and coalition-build-
ing and fundraising skills to reach the goal of increasing the consumption of fruits and 
vegetables. Following the most efficient strategy, changing behavior instead of changing 
attitudes first, their strategy is to make it possible to include free food at workplaces.
The “5 Per Day“ recommendation of fruits and vegetables is also referred to in a 2001 
article in the German popular nutrition journal “Ernährungsumschau (Nutrition Sur-
vey)”; however, the article states that the “scientific proof” for the effect of such changes 
in dietary habits is still lacking – that observational cohort studies will help provide such 
evidence.57 Large observational cohort studies are seen as a way to empirically establish 
proof of the effect of nutritional changes that will count as evidence for policy. The fact 
that for a lot of diet recommendations, there is no detailed formal proof in accordance 
with the latest standards, keeps the “need” for further studies to continue. This shows 
the data work and translation exercises conducted for rather straightforward recommen-
dations (such as “eat more fruits and vegetables”) for their implementation into health 
promotion policies. Rather than new approaches or breakthroughs, the performative 
effects of these activities are in the establishment of a novel culture of accounting and 
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Diversity managed: the creation of a common space by harmonizing  
instruments
Moreover, quantitative epidemiological risk estimates can be integrated in economic 
modeling and in cost benefit reasoning. For instance, the cost of a public health inter-
vention is measured in terms of reduction of risk in the target population. Conceptuali-
zations such as “the cost of sedentary lifestyles,” calculations of “disability-adjusted life 
years (DALYs)” and the “burden of disease in a population” bear witness to the influence 
of economic models used in the governance of population health. 
The need for comparable statistics as a prerequisite for policy has reached a status of 
being demanded by the public and much part of common sense. This justifies the huge 
effort to develop “harmonized” methods for dietary surveys, health surveys and the mon-
itoring of food. As in other fields where Europeanization takes place, a large part of the 
effort is in standardizing or “harmonizing” methods and instruments in order to enable 
comparisons within the EU. The first step towards a unified space of European product 
standards and health policy is the harmonization of methods.58 Translated into statistics 
with “harmonized methods,” diversity and regional character become visible and man-
ageable, as an apparatus of continual data generation is developing. In that sense, com-
mon or compatible measurement techniques, i.e., difference measured with a common 
standard, produce diversity in unity. In turn, these new modes of accountability justify 
policies using the means of scientific statistical evidence and cost-benefit calculations. 
Much of the production of statistics was part and parcel of techniques of government 
since the beginning of political arithmetic, population statistics and social statistics in-
cluding epidemiological studies. At the same time though, health-related statistics can 
open up a space for public debate on health as a societal issue in novel ways.59 It is in this 
“triangle” of applied health research, EU policy and bureaucracy and health governance 
through the participation of citizens that the contemporary Homo Europaeus is config-
ured. The mode of accountability and concepts of citizenship that include “active” bio-
participation, however, entail at the same time rather “passive” subject positions. In an 
opening statement too the website by the “Directorate for Health and Consumers” of the 
European Commission this reads: “Our job is to help make Europe’s citizens healthier, 
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Conclusions 
This article has looked at settings and practices of epidemiological research in the field 
of nutrition and health as a contemporary site in which the Homo Europaeus is co-pro-
duced and negotiated. Rather than following preconceived notions of a “European,” we 
have focused on the processes through which the “European” becomes a performative 
category in contemporary biomedical science and in public health policies. In this con-
text, the epidemiological study itself and its design – an observational cohort study – is 
a powerful actant: the study design is an infrastructural device and epistemic grid that 
co-determines the kinds of epistemological and social relations that are possible between 
researchers and those researched within this setting. With its rules of observation and 
bio-statistical “requirements,” the study co-organizes this relationship – in epistemologi-
cal, practical and social terms.
It is through the epidemiological study on nutrition and health that the emergence of the 
“European” takes place: The research platform and infrastructure is “EUropean” in terms 
of its organization; moreover, the “European” is performed, when a “European” study 
population is established, or a “European” repository of biological samples, i.e., when 
parts of the population function as the extended laboratory for biomedical research. 
Health scientists use this European datascape61 to measure, calculate, visualize, and even-
tually govern diversity. While the “European” as a fixed biological category only emerges 
in the comparison with the “non-European,” much of the reconfigurations of the Euro-
pean take place in implicit ways – through the ways in which patients are subjected to 
individual profiling and engaged in risk assessment in treatment decisions. Furthermore, 
it is also via the epidemiological study that the Homo Europaeus is constituted as a citizen 
both in the mode of the risk manager and bioparticipant. Heterogeneity and difference 
are made use of as a resource for knowledge production. It is precisely the establishment 
of databases that bring about Europe as unified in diversity – as a space of harmonized 
data generation. 
Thus, the contemporary European is constituted as a data producer and data consumer 
– risk manager, bioparticipant, citizen-patient – in a society that is co-shaped by regimes 
and practices of risk assessment in terms of its culture of decision-making and preventive 
risk optimization. Increasingly, the consumers themselves ask for evaluations of popula-
tion health. Beyond being a target population for health policies and governance by the 
EU and national governments, this “confident” Homo Europaeus actively enrolls into 
research and the improvement of “population health.” The ubiquity of risk assessment 
rationality and ideas about accountable, evidence-based policy-making as well as a new 
mode of “bioparticipation” co-shape the contemporary features of the Homo EUropaeus. 
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